THE REINFORCEMENT OF RENIN-ANGEOTENSIN-ALDOSTERON SYSTEMBLOCKAGE: COMPARISON OF THE RESULTS OF THE MONOTHERAPYBY CARDOSTEN AND THE COMBINATION OF CARDOSTEN AND ENALAPRILAMONG THE PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATIONWITH METABOLIC SYNDROME


Cite item

Full Text

Abstract

We studied the possibility of extra blockage of renin-angeotensin-aldosteron system as a result of combined therapy
by ultra small doses of antibodies to C-end fragment of AT-1 receptor of angiotensin II cardosten and angiotensin-converting
enzyme inhibitor among patients with the first degree arterial hypertension in combination with metabolic syndrome. The angiotensin-converting enzyme inhibitor enalapril supplement in dose of 10 mg two times a day to the monotherapy by cardosten speeds up and strengthens the hypotensive effect, it favorably influences on the data of lipid and carbohydrate
metabolism during first three months of treatment. Further the phenomenon of recession effect develops and the results
of treatment aren't different from the monotherapy by cardosten.

References

  1. Беленков Ю. Н., Оганов Р. Г. Кардиология. Национальное руководство. - М.: Гэотар-Медиа, 2007. - С. 611-624.
  2. Беленков Ю. Н., Чазова И. Е., Мычка В. Б. // Артеральные гипертензии. - 2003. - № 96. - С. 196-199.
  3. Гороховская Г. Н., Чернецова Е. В., Петина М. М. Принципы диагностики и лечения метаболического синдрома. - М., 2008. - С. 22-24.
  4. Мамедов М. Н., Косматова О. В., Чудакова И. В. и др. // Сердце. - 2006. - Т. 5, № 3 (27). - С. 129-133.
  5. Чазова И. Е., Мычка В. Б. Метаболический синдром. - М.: Media Medica, 2004.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Frolova E.V., Avdienko A.A., Frolova E.V., Avdienko A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 79562 от 27.11.2020 г.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies